Regulation of IκBα function and NF-κB signaling: AEBP1 is a novel proinflammatory mediator in macrophages

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Majdalawieh, Amin ^a   Ro, Hyo Sung ^b  

^a AMERICAN UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE ENHANCER BINDING PROTEIN 1; CARBOXYPEPTIDASE; GLUCOCORTICOID RECEPTOR; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; AEBP1 PROTEIN, HUMAN; I KAPPA B; LIVER X RECEPTOR; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REPRESSOR PROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIA TRACHOMATIS; HEPATITIS B VIRUS; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ATHEROSCLEROSIS; CARBOXYPEPTIDASES; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; MACROPHAGES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; RECEPTORS, GLUCOCORTICOID; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SHOCK, SEPTIC; SIGNAL TRANSDUCTION;

EID: 77952479173     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/823821     Document Type: Review

References (321)

1. Baeuerle P. A., Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Current Biology 1998 8 1 R19 R22
2. Tak P. P., Firestein G. S., NF-κB: a key role in inflammatory diseases Journal of Clinical Investigation 2001 107 1 7 11
3. Yamamoto Y., Gaynor R. B., Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer Journal of Clinical Investigation 2001 107 2 135 142
4. Shoelson S. E., Lee J., Yuan M., Inflammation and the IKK /I B/NF-κB axis in obesity-and diet-induced insulin resistance The International Journal of Obesity 2003 27 supplement 3 S49 S52
5. Clevers H., At the crossroads of inflammation and cancer Cell 2004 118 6 671 674
6. Kumar A., Takada Y., Boriek A. M., Aggarwal B. B., Nuclear factor-B: its role in health and disease The Journal of Molecular Medicine 2004 82 7 434 448
7. Monaco C., Paleolog E., Nuclear factor B: a potential therapeutic target in atherosclerosis and thrombosis Cardiovascular Research 2004 61 4 671 682
8. Baeuerle P. A., Baltimore D., I B: a specific inhibitor of the NF-κB transcription factor Science 1988 242 4878 540 546
9. May M. J., Ghosh S., Rel/NF-κB and I B proteins: an overview Seminars in Cancer Biology 1997 8 2 63 73
10. Ghosh S., May M. J., Kopp E. B., NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses Annual Review of Immunology 1998 16 225 260
11. Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D., Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proceedings of the National Academy of Sciences of the United States of America 1989 86 8 2839 2843
12. Barath P., Fishbein M. C., Cao J., Berenson J., Helfant R. H., Forrester J. S., Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization American Journal of Pathology 1990 137 3 503 509
13. Brand K., Fowler B. J., Edgington T. S., Mackman N., Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide Molecular and Cellular Biology 1991 11 9 4732 4738
14. Cybulsky M. I., Gimbrone M. A. Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 1991 251 4995 788 791
15. Mackman N., Brand K., Edgington T. S., Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor B binding sites Journal of Experimental Medicine 1991 174 6 1517 1526
16. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 1993 362 6423 801 809
17. Baeuerle P. A., Henkel T., Function and activation of NF-κB in the immune system Annual Review of Immunology 1994 12 141 179
18. Kopp E. B., Ghosh S., NF-κB and Rel proteins in innate immunity Advances in Immunology 1995 58 1 27
19. Baldwin A. S. Jr., The NF-κB and I B proteins: new discoveries and insights Annual Review of Immunology 1996 14 649 683
20. Yokoo T., Kitamura M., Dual regulation of IL-1-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1 American Journal of Physiology 1996 270 F123 F130
21. Mengshol J. A., Vincenti M. P., Coon C. I., Barchowsky A., Brinckerhoff C. E., Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor B: differential regulation of collagenase 1 and collagenase 3 Arthritis and Rheumatism 2000 43 4 801 811
22. Sha W. C., Liou H. C., Tuomanen E. I., Baltimore D., Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses Cell 1995 80 2 321 330
23. Caamao J. H., Rizzo C. A., Durham S. K., Nuclear factor (NF)-B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses Journal of Experimental Medicine 1998 187 2 185 196
24. Franzoso G., Carlson L., Poljak L., Mice deficient in nuclear factor (NF)-B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture Journal of Experimental Medicine 1998 187 2 147 159
25. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D., Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB Nature 1995 376 6536 167 170
26. Doi T. S., Takahashi T., Taguchi O., Azuma T., Obata Y., NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses Journal of Experimental Medicine 1997 185 5 953 961
27. Alcamo E., Mizgerd J. P., Horwitz B. H., Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment Journal of Immunology 2001 167 3 1592 1600
28. Kontgen F., Grumont R. J., Strasser A., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression Genes Development 1995 9 16 1965 1977
29. Weih F., Carrasco D., Durham S. K., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family Cell 1995 80 2 331 340
30. Brand K., Page S., Rogler G., Activated transcription factor nuclear factor-B is present in the atherosclerotic lesion Journal of Clinical Investigation 1996 97 7 1715 1722
31. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis Journal of Neuroimmunology 1994 55 1 99 106
32. Parhami F., Fang Z. T., Fogelman A. M., Andalibi A., Territo M. C., Berliner J. A., Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate Journal of Clinical Investigation 1993 92 1 471 478
33. Peng H.-B., Rajavashisth T. B., Libby P., Liao J. K., Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells Journal of Biological Chemistry 1995 270 28 17050 17055
34. Rajavashisth T. B., Yamada H., Mishra N. K., Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL: involvement of nuclear factor-B Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 10 1591 1598
35. Brand K., Eisele T., Kreusel U., Dysregulation of monocytic nuclear factor-B by oxidized low-density lipoprotein Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 10 1901 1909
36. Brand K., Page S., Walli A. K., Neumeier D., Baeuerle P. A., Role of nuclear factor-B in atherogenesis Experimental Physiology 1997 82 2 297 304
37. Wolfrum S., Teupser D., Tan M., Chen K. Y., Breslow J. L., The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18601 18606
38. Gareus R., Kotsaki E., Xanthoulea S., Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis Cell Metabolism 2008 8 5 372 383
39. Kim K. M., Choi J. Y., Yoo S.-E., HMCO5, herbal extract, inhibits NF-κB expression in lipopolysaccharide treated macrophages and reduces atherosclerotic lesions in cholesterol fed mice Journal of Ethnopharmacology 2007 114 3 316 324
40. Wang L., Geng C., Jiang L., The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis European Journal of Nutrition 2008 47 5 235 243
41. Wang J., Zhang R., Xu Y., Zhou H., Wang B., Li S., Genistein inhibits the development of atherosclerosis via inhibiting NF-κB and VCAM-1 expression in LDLR knockout mice Canadian Journal of Physiology and Pharmacology 2008 86 11 777 784
42. Liu Y., Yan F., Liu Y., Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation Phytotherapy Research 2008 22 7 935 942
43. Li H., Dai M., Jia W., Paeonol attenuates high-fat-diet-induced atherosclerosis in rabbits by anti-inflammatory activity Planta Medica 2009 75 1 7 11
44. Thourani V. H., Brar S. S., Kennedy T. P., Nonanticoagulant heparin inhibits NF-κB activation and attenuates myocardial reperfusion injury American Journal of Physiology 2000 278 6 H2084 H2093
45. Sasaki H., Ray P. S., Zhu L., Galang N., Maulik N., Oxidative stress due to hypoxia/reoxygenation induces angiogenic factor VEGF in adult rat myocardium: possible role of NF B Toxicology 2000 155 13 27 35
46. Sasaki H., Ray P. S., Zhu L., Otani H., Asahara T., Maulik N., Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF B-dependent mechanism in a rat model of chronic myocardial infarction Journal of Molecular and Cellular Cardiology 2001 33 2 283 294
47. Yoshiyama M., Omura T., Takeuchi K., Angiotensin blockade inhibits increased JNKs, AP-1 and NF B DNA-binding activities in myocardial infarcted rats Journal of Molecular and Cellular Cardiology 2001 33 4 799 810
48. Izumi T., Saito Y., Kishimoto I., Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-κB activation and alleviates myocardial ischemia/reperfusion injury Journal of Clinical Investigation 2001 108 2 203 213
49. Shimizu M., Tamamori-Adachi M., Arai H., Tabuchi N., Tanaka H., Sunamori M., Lipopolysaccharide pretreatment attenuates myocardial infarct size: a possible mechanism involving heat shock protein 70-inhibitory B complex and attenuation of nuclear factor B Journal of Thoracic and Cardiovascular Surgery 2002 124 5 933 941
50. Thiemermann C., Inhibition of the activation of nuclear factor B to reduce myocardial reperfusion injury and infarct size Cardiovascular Research 2004 63 1 8 10
51. Lu L., Chen S. S., Zhang J. Q., Ramires F. J., Sun Y., Activation of nuclear factor-B and its proinflammatory mediator cascade in the infarcted rat heart Biochemical and Biophysical Research Communications 2004 321 4 879 885
52. Verma I. M., Stevenson J. K., Schwarz E. M., van Antwerp D., Miyamoto S., Rel/NF-κB/I B family: intimate tales of association and dissociation Genes Development 1995 9 22 2723 2735
53. Kawakami K., Scheidereit C., Roeder R. G., Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro Proceedings of the National Academy of Sciences of the United States of America 1988 85 13 4700 4704
54. Baeuerle P. A., Baltimore D., A 65-D subunit of active NF-κB is required for inhibition of NF-κB by I B Genes Development 1989 3 11 1689 1698
55. Ghosh S., Gifford A. M., Riviere L. R., Tempst P., Nolan G. P., Baltimore D., Cloning of the p50 DNA binding subunit of NF-κB: homology to Rel and dorsal Cell 1990 62 5 1019 1029
56. 2+ dependence, and differential half-site recognition Journal of Biological Chemistry 1991 266 1 252 260
57. + T lymphocytes Science 1992 256 5062 1452 1455
58. Plaksin D., Baeuerle P. A., Eisenbach L., KBF1 (p50 NF-κB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells Journal of Experimental Medicine 1993 177 6 1651 1662
59. Brown A. M., Linhoff M. W., Stein B., Function of NF-κB/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-κB/Rel subunits Molecular and Cellular Biology 1994 14 5 2926 2935
60. Blair W. S., Bogerd H. P., Madore S. J., Cullen B. R., Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module Molecular and Cellular Biology 1994 14 11 7226 7234
61. Dobrzanski P., Ryseck R. P., Bravo R., Both N-and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif Molecular and Cellular Biology 1993 13 3 1572 1582
62. Ghosh S., Baltimore D., Activation in vitro of NF-κB by phosphorylation of its inhibitor I B Nature 1990 344 6267 678 682
63. Israel A., The IKK complex: an integrator of all signals that activate NF-κB? Trends in Cell Biology 2000 10 4 129 133
64. Hayden M. S., Ghosh S., Signaling to NF-κB Genes Development 2004 18 18 2195 2224
65. Mosialos G., Hamer P., Capobianco A. J., Laursen R. A., Gilmore T. D., A protein kinase-A recognition sequence is structurally linked to transformation by p59(v-rel) and cytoplasmic retention of p68(c-rel) Molecular and Cellular Biology 1991 11 12 5867 5877
66. Norris J. L., Manley J. L., Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase A Genes Development 1992 6 9 1654 1667
67. Naumann M., Scheidereit C., Activation of NF-κB in vivo is regulated by multiple phosphorylations EMBO Journal 1994 13 19 4597 4607
68. Li C. C. H., Dai R. M., Chen E., Longo D. L., Phosphorylation of NF-κB1-p50 is involved in NF-κB activation and stable DNA binding Journal of Biological Chemistry 1994 269 48 30089 30092
69. Li C. C. H., Korner M., Ferris D. K., Chen E., Dai R. M., Longo D. L., NF-κB/Rel family members are physically associated phosphoproteins Biochemical Journal 1994 303 2 499 506
70. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S., The transcriptional activity of NF-κB is regulated by the I B-associated PKAc subunit through a cyclic AMP-independent mechanism Cell 1997 89 3 413 424
71. Vermeulen L., De Wilde G., van Damme P., Vanden Berghe W., Haegeman G., Transcriptional activation of the NF-κB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1) EMBO Journal 2003 22 1313 1324
72. Zhong H., Voll R. E., Ghosh S., Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 Molecular Cell 1998 1 5 661 671
73. Zhong H., May M. J., Jimi E., Ghosh S., The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1 Molecular Cell 2002 9 3 625 636
74. Duran A., Diaz-Meco M. T., Moscat J., Essential role of RelA Ser311 phosphorylation by PKC in NF-κB transcriptional activation EMBO Journal 2003 22 15 3910 3918
75. Wang D., Westerheide S. D., Hanson J. L., Baldwin A. S. Jr., Tumor necrosis factor-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II Journal of Biological Chemistry 2000 275 42 32592 32597
76. Sakurai H., Chiba H., Miyoshi H., Sugita T., Toriumi W., I B kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain Journal of Biological Chemistry 1999 274 43 30353 30356
77. Jiang X., Takahashi N., Matsui N., Tetsuka T., Okamoto T., The NF-κB activation in lymphotoxin receptor signaling depends on the phosphorylation of p65 at serine 536 Journal of Biological Chemistry 2003 278 2 919 926
78. OMahony A. M., Montano M., van Beneden K., Chen L.-F., Greene W. C., Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires I B kinase-1-mediated phosphorylation of RelA/p65 Journal of Biological Chemistry 2004 279 18 18137 18145
79. Madrid L. V., Mayo M. W., Reuther J. Y., Baldwin A. S. Jr., Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the I B kinase and activation of the mitogen-activated protein kinase p38 Journal of Biological Chemistry 2001 276 22 18934 18940
80. Sizemore N., Leung S., Stark G. R., Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit Molecular and Cellular Biology 1999 19 7 4798 4805
81. Bohuslav J., Chen L.-F., Kwon H., Mu Y., Greene W. C., p53 induces NF-κB activation by an I B kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1 Journal of Biological Chemistry 2004 279 25 26115 26125
82. Fujita F., Taniguchi Y., Kato T., Identification of NAP1, a regulatory subunit of I B kinase-related kinases that potentiates NF-κB signaling Molecular and Cellular Biology 2003 23 21 7780 7793
83. Buss H., Dorrie A., Schmitz M. L., Hoffmann E., Resch K., Kracht M., Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including I B kinase (IKK)-, IKK, IKK, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription Journal of Biological Chemistry 2004 279 53 55633 55643
84. Logeat F., Israel N., Ten R., Inhibition of transcription factors belonging to the rel/NF-κB family by a transdominant negative mutant EMBO Journal 1991 10 7 1827 1832
85. Ruben S. M., Narayanan R., Klement J. F., Chen C.-H., Rosen C. A., Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative Molecular and Cellular Biology 1992 12 2 444 454
86. Ganchi P. A., Sun S.-C., Greene W. C., Ballard D. W., A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization Molecular and Cellular Biology 1993 13 12 7826 7835
87. Ryseck R.-P., Novotny J., Bravo R., Characterization of elements determining the dimerization properties of RelB and p50 Molecular and Cellular Biology 1995 15 6 3100 3109
88. Kunsch C., Ruben S. M., Rosen C. A., Selection of optimal B/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation Molecular and Cellular Biology 1992 12 10 4412 4421
89. Rice N. R., MacKichan M. L., Israel A., The precursor of NF-κB p50 has I B-like functions Cell 1992 71 2 243 253
90. Bressler P., Brown K., Timmer W., Bours V., Siebenlist U., Fauci A. S., Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant p50 mutants Journal of Virology 1993 67 1 288 293
91. Baeuerle P. A., Baltimore D., Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor Cell 1988 53 2 211 217
92. Zabel U., Baeuerle P. A., Purified human I B can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA Cell 1990 61 2 255 265
93. Whiteside S. T., Israel A., I B proteins: structure, function and regulation Seminars in Cancer Biology 1997 8 2 75 82
94. Totzke G., Essmann F., Pohlmann S., Lindenblatt C., Janicke R. U., Schulze-Osthoff K., A novel member of the I B family, human I B, inhibits transactivation of p65 and its DNA binding Journal of Biological Chemistry 2006 281 18 12645 12654
95. Zhang Q., Didonato J. A., Karin M., Mckeithan T. W., BCL3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins Molecular and Cellular Biology 1994 14 6 3915 3926
96. Franzoso G., Bours V., Park S., Tomita-Yamaguchi M., Kelly K., Siebenlist U., The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB- mediated inhibition Nature 1992 359 6393 339 342
97. Franzoso G., Bours V., Azarenko V., The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select B sites EMBO Journal 1993 12 10 3893 3901
98. Inoue J., Takahara T., Akizawa T., Hino O., Bcl-3, a member of the I B proteins, has distinct specificity towards the Rel family of proteins Oncogene 1993 8 8 2067 2073
99. Haskill S., Beg A. A., Tompkins S. M., Characterization of an immediate-early gene induced in adherent monocytes that encodes I B-like activity Cell 1991 65 7 1281 1289
100. Davis N., Ghosh S., Simmons D. L., Rel-associated pp40: an inhibitor of the Rel family of transcription factors Science 1991 253 5025 1268 1271
101. Beg A. A., Baldwin A. S. Jr., The I B proteins: multifunctional regulators of Rel/NF-κB transcription factors Genes Development 1993 7 11 2064 2070
102. Breeden L., Nasmyth K., Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila Nature 1987 329 6140 651 654
103. Lux S. E., John K. M., Bennett V., Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins Nature 1990 344 6261 36 42
104. Michaely P., Bennett V., The ANK repeat: a ubiquitous motif involved in macromolecular recognition Trends in Cell Biology 1992 2 5 127 129
105. Davis J. Q., Bennett V., The anion exchanger and Na+ K+-ATPase interact with distinct sites on ankyrin in in vitro assays Journal of Biological Chemistry 1990 265 28 17252 17256
106. Hatada E. N., Nieters A., Wulczyn F. G., The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene Bcl-3 act as specific inhibitors of NF-κB DNA binding Proceedings of the National Academy of Sciences of the United States of America 1992 89 6 2489 2493
107. Inoue J.-I., Kerr L. D., Rashid D., Davis N., Bose H. R. Jr., Verma I. M., Direct association of pp40/I B with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4333 4337
108. Ganchi P. A., Sun S.-C., Greene W. C., Ballard D. W., I B/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding Molecular Biology of the Cell 1992 3 12 1339 1352
109. Ernst M. K., Dunn L. L., Rice N. R., The PEST-like sequence of I B is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers Molecular and Cellular Biology 1995 15 2 872 882
110. Beauparlant P., Lin R., Hiscott J., The role of the C-terminal domain of I B in protein degradation and stabilization Journal of Biological Chemistry 1996 271 18 10690 10696
111. McElhinny J. A., Trushin S. A., Bren G. D., Chester N., Paya C. V., Casein kinase II phosphorylates I B at S-283, S-289, S-293, and T-291 and is required for its degradation Molecular and Cellular Biology 1996 16 3 899 906 (Pubitemid 26061660)
112. Lin R., Beauparlant P., Makris C., Meloche S., Hiscott J., Phosphorylation of I B in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability Molecular and Cellular Biology 1996 16 4 1401 1409
113. Schwarz E. M., van Antwerp D., Verma I. M., Constitutive phosphorylation of I B by casein kinase II occurs preferentially at serine 293: requirement for degradation of free I B Molecular and Cellular Biology 1996 16 7 3554 3559
114. Brockman J. A., Scherer D. C., McKinsey T. A., Coupling of a signal response domain in I B to multiple pathways for NF-κB activation Molecular and Cellular Biology 1995 15 5 2809 2818
115. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U., Control of I B-proteolysis by site-specific, signal-induced phosphorylation Science 1995 267 5203 1485 1488
116. Traenckner E. B.-M., Pahl H. L., Henkel T., Schmidt K. N., Wilk S., Baeuerle P. A., Phosphorylation of human I B-on serines 32 and 36 controls I B-proteolysis and NF-κB activation in response to diverse stimuli EMBO Journal 1995 14 12 2876 2883
117. Whiteside S. T., Ernst M. K., LeBail O., Laurent-Winter C., Rice N., Israel A., N-and C-terminal sequences control degradation of MAD3/I B in response to inducers of NF-κB activity Molecular and Cellular Biology 1995 15 10 5339 5345
118. Leveillard T., Verma I. M., Diverse molecular mechanisms of inhibition of NF-κB/DNA binding complexes by I B proteins Gene Expression 1993 3 2 135 150
119. Johnson C., van Antwerp D., Hope T. J., An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of I B EMBO Journal 1999 18 23 6682 6693
120. Arenzana-Seisdedos F., Turpin P., Rodriguez M., Nuclear localization of I B promotes active transport of NF-κB from the nucleus to the cytoplasm Journal of Cell Science 1997 110 3 369 378
121. Ghosh G., van Duyne G., Ghosh S., Sigler P. B., Structure of NF-κB p50 homodimer bound to a B site Nature 1995 373 6512 303 310
122. Muller C. W., Rey F. A., Sodeoka M., Verdine G. L., Harrison S. C., Structure of the NF-κB p50 homodimer bound to DNA Nature 1995 373 6512 311 317
123. Beg A. A., Ruben S. M., Scheinman R. I., Haskill S., Rosen C. A., Baldwin A. S. Jr., I B interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention Genes Development 1992 6 10 1899 1913
124. Henkel T., Zabel U., van Zee K., Muller J. M., Fanning E., Baeuerle P. A., Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit Cell 1992 68 6 1121 1133
125. Zabel U., Henkel T., Silva M. S., Baeuerle P. A., Nuclear uptake control of NF-κB by MAD-3, an I B protein present in the nucleus EMBO Journal 1993 12 1 201 211
126. Dobrzanski P., Ryseck R.-P., Bravo R., Differential interactions of Rel-NF-κB complexes with I B determine pools of constitutive and inducible NF-κB activity EMBO Journal 1994 13 19 4608 4616
127. Simeonidis S., Stauber D., Chen G., Hendrickson W. A., Thanos D., Mechanisms by which I B proteins control NF-κB activity Proceedings of the National Academy of Sciences of the United States of America 1999 96 1 49 54
128. Suyang H., Phillips R., Douglas I., Ghosh S., Role of unphosphorylated, newly synthesized I B in persistent activation of NF-κB Molecular and Cellular Biology 1996 16 10 5444 5449
129. Sun S.-C., Ganchi P. A., Ballard D. W., Greene W. C., NF-κB controls expression of inhibitor I B : evidence for an inducible autoregulatory pathway Science 1993 259 5103 1912 1915
130. Cheng Q., Cant C. A., Moll T., NF-κB subunit-specific regulation of the I B promoter Journal of Biological Chemistry 1994 269 18 13551 13557
131. Chiao P. J., Miyamoto S., Verma I. M., Autoregulation of I B activity Proceedings of the National Academy of Sciences of the United States of America 1994 91 1 28 32
132. Arenzana-Seisdedos F., Thompson J., Rodriguez M. S., Bachelerie F., Thomas D., Hay R. T., Inducible nuclear expression of newly synthesized I B negatively regulates DNA-binding and transcriptional activities of NF-κB Molecular and Cellular Biology 1995 15 5 2689 2696
133. Luo J.-L., Kamata H., Karin M., IKK/NF-κB signaling: balancing life and deatha new approach to cancer therapy Journal of Clinical Investigation 2005 115 10 2625 2632
134. Viatour P., Merville M.-P., Bours V., Chariot A., Phosphorylation of NF-κB and I B proteins: implications in cancer and inflammation Trends in Biochemical Sciences 2005 30 1 43 52
135. Mercurio F., Zhu H., Murray B. W., IKK-1 and IKK-2: cytokine-activated I B kinases essential for NF-κB activation Science 1997 278 5339 860 866
136. Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V., I B kinase-: NF-κB activation and complex formation with I B kinase-and NIK Science 1997 278 5339 866 869
137. Zandi E., Rothwarf D. M., Delhase M., Hayakawa M., Karin M., The I B kinase complex (IKK) contains two kinase subunits, IKK and IKK, necessary for I B phosphorylation and NF-κB activation Cell 1997 91 2 243 252
138. Rothwarf D. M., Zandi E., Natoli G., Karin M., IKK-is an essential regulatory subunit of the I B kinase complex Nature 1998 395 6699 297 300
139. Yamaoka S., Courtois G., Bessia C., Complementation cloning of NEMO, a component of the I B kinase complex essential for NF-κB activation Cell 1998 93 7 1231 1240
140. Mercurio F., Murray B. W., Shevchenko A., I B kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex Molecular and Cellular Biology 1999 19 2 1526 1538
141. Mellits K. H., Hay R. T., Goodbourn S., Proteolytic degradation of MAD3 (I B) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB Nucleic Acids Research 1993 21 22 5059 5066
142. Barroga C. F., Stevenson J. K., Schwarz E. M., Verma I. M., Constitutive phosphorylation of I B by casein kinase II Proceedings of the National Academy of Sciences of the United States of America 1995 92 17 7637 7641
143. Weil R., Laurent-Winter C., Israel A., Regulation of I B degradation: similarities to and differences from I B Journal of Biological Chemistry 1997 272 15 9942 9949
144. Krappmann D., Wulczyn F. G., Scheidereit C., Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor I B in vivo EMBO Journal 1996 15 23 6716 6726
145. Miyamoto S., Seufzer B. J., Shumway S. D., Novel I B proteolytic pathway in WEHI231 immature B cells Molecular and Cellular Biology 1998 18 1 19 29
146. Phillips R. J., Ghosh S., Regulation of I B in WEHI 231 mature B cells Molecular and Cellular Biology 1997 17 8 4390 4396
147. Shumway S. D., Miyamoto S., A mechanistic insight into a proteasome-independent constitutive inhibitor B (I B) degradation and nuclear factor B (NF-κB) activation pathway in WEHI-231 B-cells Biochemical Journal 2004 380 1 173 180
148. Shumway S. D., Maki M., Miyamoto S., The PEST domain of I B is necessary and sufficient for in vitro degradation by-calpain Journal of Biological Chemistry 1999 274 43 30874 39881
149. Shumway S. D., Berchtold C. M., Gould M. N., Miyamoto S., Evidence for unique calmodulin-dependent nuclear factor-B regulation in WEHI-231 B cells Molecular Pharmacology 2002 61 1 177 185
150. Jiang Y., Woronicz J. D., Liu W., Goeddel D. V., Prevention of constitutive TNF receptor 1 signaling by silencer of death domains Science 1999 283 5401 543 546
151. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J.-I., Cao Z., Matsumoto K., The kinase TAK1 can activate the NIK-I B as well as the MAP kinase cascade in the IL-1 signalling pathway Nature 1999 398 6724 252 256
152. Takeuchi O., Akira S., Toll-like receptors; their physiological role and signal transduction system International Immunopharmacology 2001 1 4 625 635
153. Nemoto S., DiDonato J. A., Lin A., Coordinate regulation of I B kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase Molecular and Cellular Biology 1998 18 12 7336 7343 (Pubitemid 28533053)
154. Ducut Sigala J. L., Bottero V., Young D. B., Shevchenko A., Mercurio F., Verma I. M., Activation of transcription factor NF-κB requiries ELKS, an I B kinase regulatory subunit Science 2004 304 5679 1963 1967
155. Regnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M., Identification and characterization of an I B kinase Cell 1997 90 2 373 383
156. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M., A cytokine-responsive I B kinase that activates the transcription factor NF-κB Nature 1997 388 6642 548 554
157. Zandi E., Karin M., Bridging the gap: composition, regulation, and physiological function of the I B kinase complex Molecular and Cellular Biology 1999 19 7 4547 4551
158. Nakano H., Shindo M., Sakon S., Differential regulation of I B kinase and by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3537 3542
159. Wu C., Ghosh S., Differential phosphorylation of the signal-responsive domain of I B and I B by I B kinases Journal of Biological Chemistry 2003 278 34 31980 31987
160. Zandi E., Chen Y., Karin M., Direct phosphorylation of I B by IKK and IKK : discrimination between free and NF-κB-bound substrate Science 1998 281 5381 1360 1363
161. Ling L., Cao Z., Goeddel D. V., Nf-B-inducing kinase activates IKK-by phosphorylation of Ser-176 Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3792 3797
162. Delhase M., Hayakawa M., Chen Y., Karin M., Positive and negative regulation of I B kinase activity through IKK subunit phosphorylation Science 1999 284 5412 309 313
163. Hu Y., Baud V., Delhase M., Abnormal morphogenesis but intact IKK activation in mice lacking the IKK subunit of I B kinase Science 1999 284 5412 316 320
164. Li Z.-W., Chu W., Hu Y., The IKK subunit of I B kinase (IKK) is essential for nuclear factor B activation and prevention of apoptosis Journal of Experimental Medicine 1999 189 11 1839 1845
165. Doi T. S., Marino M. W., Takahashi T., Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2994 2999
166. Beg A. A., Baltimore D., An essential role for NF-κB in preventing TNF-α-induced cell death Science 1996 274 5288 782 784
167. DiDonato J. A., Mercurio F., Karin M., Phosphorylation of I B precedes but is not sufficient for its dissociation from NF-κB Molecular and Cellular Biology 1995 15 3 1302 1311
168. Traenckner E. B.-M., Baeuerle P. A., Appearance of apparently ubiquitin-conjugated I B-during its phosphorylation-induced degradation in intact cells Journal of Cell Science 1995 19 79 84
169. Chen Z., Hagler J., Palombella V. J., Signal-induced site-specific phosphorylation targets I B to the ubiquitin-proteasome pathway Genes Development 1995 9 13 1586 1597
170. Alkalay I., Yaron A., Hatzubai A., Orian A., Ciechanover A., Ben-Neriah Y., Stimulation-dependent I B phosphorylation marks the NF-b inhibitor for degradation via the ubiquitin-proteasome pathway Proceedings of the National Academy of Sciences of the United States of America 1995 92 23 10599 10603
171. Li C.-C. H., Dai R.-M., Longo D. L., Inactivation of NF-κB inhibitor I B : ubiquitin-dependent proteolysis and its degradation product Biochemical and Biophysical Research Communications 1995 215 1 292 301
172. Ciechanover A., The ubiquitin-proteasome proteolytic pathway Cell 1994 79 1 13 21
173. Hochstrasser M., Ubiquitin, proteasomes, and the regulation of intracellular protein degradation Current Opinion in Cell Biology 1995 7 2 215 223
174. Murray A., Cyclin ubiquitination: the destructive end of mitosis Cell 1995 81 2 149 152
175. Wilkinson K. D., Ubiquitin-dependent signaling: the role of ubiquitination in the response of cells to their environment Journal of Nutrition 1999 129 11 1933 1936
176. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., Baeuerle P. A., Rapid proteolysis of I B-is necessary for activation of transcription factor NF-κB Nature 1993 365 6442 182 185
177. Sun S.-C., Elwood J., Beraud C., Greene W. C., Human T-cell leukemia virus type I Tax activation of NF-κB/Rel involves phosphorylation and degradation of I B and RelA (p65)-mediated induction of the c-rel gene Molecular and Cellular Biology 1994 14 11 7377 7384
178. Traenckner E. B.-M., Wilk S., Baeuerle P. A., A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of I B-that is still bound to NF-κB EMBO Journal 1994 13 22 5433 5441
179. Finco T. S., Beg A. A., Baldwin A. S. Jr., Inducible phosphorylation of I B is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors Proceedings of the National Academy of Sciences of the United States of America 1994 91 25 11884 11888
180. Miyamoto S., Maki M., Schmitt M. J., Hatanaka M., Verma I. M., Tumor necrosis factor-induced phosphorylation of I B is a signal for its degradation but not dissociation from NF-κB Proceedings of the National Academy of Sciences of the United States of America 1994 91 26 12740 12744
181. Lin Y.-C., Brown K., Siebenlist U., Activation of NF-κB requires proteolysis of the inhibitor I B-: signal-induced phosphorylation of I B-alone does not release active NF-κB Proceedings of the National Academy of Sciences of the United States of America 1995 92 2 552 556
182. Alkalay I., Yaron A., Hatzubai A., In vivo stimulation of I B phosphorylation is not sufficient to activate NF-κB Molecular and Cellular Biology 1995 15 3 1294 1301
183. Hartmann-Petersen R., Gordon C., Proteins interacting with the 26S proteasome Cellular and Molecular Life Sciences 2004 61 13 1589 1595
184. Palombella V. J., Rando O. J., Goldberg A. L., Maniatis T., The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB Cell 1994 78 5 773 785
185. Rodriguez M. S., Wright J., Thompson J., Identification of lysine residues required for signal-induced ubiquitination and degradation of I B-in vivo Oncogene 1996 12 11 2425 2435
186. Griscavage J. M., Wilk S., Ignarro L. J., Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-κB Proceedings of the National Academy of Sciences of the United States of America 1996 93 8 3308 3312
187. Scherer D. C., Brockman J. A., Chen Z., Maniatis T., Ballard D. W., Signal-induced degradation of I B requires site-specific ubiquitination Proceedings of the National Academy of Sciences of the United States of America 1995 92 24 11259 11263
188. Baldi L., Brown K., Franzoso G., Siebenlist U., Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I B-Journal of Biological Chemistry 1996 271 1 376 379
189. Rodriguez M. S., Michalopoulos I., Arenzana-Seisdedos F., Hay R. T., Inducible degradation of I B in vitro and in vivo requires the acidic C-terminal domain of the protein Molecular and Cellular Biology 1995 15 5 2413 2419
190. Aoki T., Sano Y., Yamamoto T., Inoue J.-I., The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of I B Oncogene 1996 12 5 1159 1164
191. Sun S.-C., Elwood J., Greene W. C., Both amino-and carboxyl-terminal sequences within I B regulate its inducible degradation Molecular and Cellular Biology 1996 16 3 1058 1065
192. DiDonato J., Mercurio F., Rosette C., Mapping of the inducible I B phosphorylation sites that signal its ubiquitination and degradation Molecular and Cellular Biology 1996 16 4 1295 1304
193. Harhaj E. W., Maggirwar S. B., Good L., Sun S.-C., CD28 mediates a potent costimulatory signal for rapid degradation of I B which is associated with accelerated activation of various NF-κB/Rel heterodimers Molecular and Cellular Biology 1996 16 12 6736 6743
194. McKinsey T. A., Brockman J. A., Scherer D. C., Al-Murrani S. W., Green P. L., Ballard D. W., Inactivation of I B by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB Molecular and Cellular Biology 1996 16 5 2083 2090
195. Dohmen R. J., SUMO protein modification Biochimica et Biophysica Acta 2004 1695 13 113 131
196. Hay R. T., SUMO: a history of modification Molecular Cell 2005 18 1 1 12
197. Mabb A. M., Miyamoto S., SUMO and NF-κB ties Cellular and Molecular Life Sciences 2007 64 15 1979 1996
198. Liu B., Shuai K., Regulation of the sumoylation system in gene expression Current Opinion in Cell Biology 2008 20 3 288 293
199. Desterro J. M. P., Rodriguez M. S., Hay R. T., SUMO-1 modification of I B inhibits NF-κB activation Molecular Cell 1998 2 2 233 239
200. Rodriguez M. S., Dargemont C., Hay R. T., SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting Journal of Biological Chemistry 2001 276 16 12654 12659
201. Guo D., Li M., Zhang Y., A functional variant of SUMO4, a new I B modifier, is associated with type diabetes Nature Genetics 2004 36 8 837 841
202. Wang C.-Y., Yang P., Li M., Gong F., Characterization of a negative feedback network between SUMO4 expression and NF B transcriptional activity Biochemical and Biophysical Research Communications 2009 381 4 477 481
203. Matunis M. J., Coutavas E., Blobel G., A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex Journal of Cell Biology 1996 135 6 1457 1470
204. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F., A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2 Cell 1997 88 1 97 107
205. Mller S., Matunis M. J., Dejean A., Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus EMBO Journal 1998 17 1 61 70
206. Kim J. H., Baek S. H., Emerging roles of desumoylating enzymes Biochimica et Biophysica Acta 2009 1792 3 155 162
207. Comerford K. M., Leonard M. O., Karhausen J., Carey R., Colgan S. P., Taylor C. T., Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 986 991
208. Liu Q., Li J., Khoury J., Colgan S. P., Ibla J. C., Adenosine signaling mediates SUMO-1 modification of I B during hypoxia and reoxygenation Journal of Biological Chemistry 2009 284 20 13686 13695
209. Noso S., Ikegami H., Fujisawa T., Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes Diabetes 2005 54 12 3582 3586
210. Tsurumaru M., Kawasaki E., Ida H., Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population Journal of Clinical Endocrinology and Metabolism 2006 91 8 3138 3143
211. Wang C.-Y., She J.-X., SUMO4 and its role in type 1 diabetes pathogenesis Diabetes/Metabolism Research and Reviews 2008 24 2 93 102
212. Jennings C. E., Owen C. J., Wilson V., Pearce S. H. S., No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves disease Clinical Endocrinology 2005 62 3 362 365
213. Gibbons L. J., Thomson W., Zeggini E., The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis Rheumatology 2005 44 11 1390 1393
214. Costas J., Perez-Pampin E., Ferreiros-Vidal I., SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis Journal of Rheumatology 2006 33 6 1048 1051
215. Orozco G., Snchez E., Gonzlez-Gay M. A., SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population Journal of Rheumatology 2006 33 7 1235 1239
216. Orozco G., Snchez E., Gmez L. M., Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus Annals of the Rheumatic Diseases 2006 65 6 791 795
217. Huang T. T., Wuerzberger-Davis S. M., Wu Z.-H., Miyamoto S., Sequential modification of NEMO/IKK by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress Cell 2003 115 5 565 576
218. Wuerzberger-Davis S. M., Nakamura Y., Seufzer B. J., Miyamoto S., NF-κB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage Oncogene 2007 26 5 641 651
219. Mabb A. M., Wuerzberger-Davis S. M., Miyamoto S., PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress Nature Cell Biology 2006 8 9 986 993
220. Perkins N. D., Post-translational modifications regulating the activity and function of the nuclear factor B pathway Oncogene 2006 25 51 6717 6730
221. Neumann M., Naumann M., Beyond I Bs: alternative regulation of NF-κB activity FASEB Journal 2007 21 11 2642 2654
222. Marienfeld R., Berberich-Siebelt F., Berberich I., Denk A., Serfling E., Neumann M., Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control Oncogene 2001 20 56 8142 8147
223. Maier H. J., Marienfeld R., Wirth T., Baumann B., Critical role of RelB serine 368 for dimerization and p100 stabilization Journal of Biological Chemistry 2003 278 40 39242 39250
224. Druker B. J., Neumann M., Okuda K., Franza B. R. Jr., Griffin J. D., rel Is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating factor treatment of human neutrophils Journal of Biological Chemistry 1994 269 7 5387 5390
225. Fognani C., Rondi R., Romano A., Blasi F., cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain Oncogene 2000 19 18 2224 2232
226. Martin A. G., Fresno M., Tumor necrosis factor-activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel Journal of Biological Chemistry 2000 275 32 24383 24391
227. Yu S.-H., Chiang W.-C., Shih H.-M., Wu K.-J., Stimulation of c-Rel transcriptional activity by PKA catalytic subunit The Journal of Molecular Medicine 2004 82 9 621 628
228. Harris J., Olire S., Sharma S., Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK The Journal of Immunology 2006 177 4 2527 2535
229. Snchez-Valdepeas C., Martn A. G., Ramakrishnan P., Wallach D., Fresno M., NF-κB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity The Journal of Immunology 2006 176 8 4666 4674
230. Guan H., Hou S., Ricciardi R. P., DNA binding of repressor nuclear factor-B p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit Journal of Biological Chemistry 2005 280 11 9957 9962
231. Ray A., Prefontaine K. E., Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor Proceedings of the National Academy of Sciences of the United States of America 1994 91 2 752 756
232. Caldenhoven E., Liden J., Wissink S., Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids Molecular Endocrinology 1995 9 4 401 412
233. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A., Baldwin A. S. Jr., Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors Molecular and Cellular Biology 1995 15 2 943 953
234. Liden J., Rafter I., Truss M., Gustafsson J.-A., Okret S., Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene Biochemical and Biophysical Research Communications 2000 273 3 1008 1014
235. Nissen R. M., Yamamoto K. R., The glucocorticoid receptor inhibits NF B by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain Genes Development 2000 14 18 2314 2329
236. Martens C., Bilodeau S., Maira M., Gauthier Y., Drouin J., Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor Molecular Endocrinology 2005 19 4 885 897
237. Reichardt H. M., Kaestner K. H., Tuckermann J., DNA binding of the glucocorticoid receptor is not essential for survival Cell 1998 93 4 531 541
238. Reichardt H. M., Tuckermann J. P., Gttlicher M., Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor EMBO Journal 2001 20 24 7168 7173
239. Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M., Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of I B synthesis Science 1995 270 5234 286 290
240. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S. Jr., Role of transcriptional activation of I B in mediation of immunosuppression by glucocorticoids Science 1995 270 5234 283 286
241. Brostjan C., Anrather J., Csizmadia V., Glucocorticoid-mediated repression of NF B activity in endothelial cells does not involve induction of I B synthesis Journal of Biological Chemistry 1996 271 32 19612 19616
242. Heck S., Bender K., Kullmann M., Gttlicher M., Herrlich P., Cato A. C. B., I B-independent downregulation of NF-κB activity by glucocorticoid receptor EMBO Journal 1997 16 15 4698 4707
243. Newton R., Hart L. A., Stevens D. A., Effect of dexamethasone on interleukin-1-(IL-1)-induced nuclear factor-B (NF-κB) and B-dependent transcription in epithelial cells The European Journal of Biochemistry 1998 254 1 81 89
244. Wissink S., van Heerde E. C., van der Burg B., van der Saag P. T., A dual mechanism mediates repression of NF-κB activity by glucocorticoids Molecular Endocrinology 1998 12 3 355 363
245. de Bosscher K., Vanden Berghe W., Haegeman G., The interplay between the glucocorticoid receptor and nuclear factor-B or activator protein-1: molecular mechanisms for gene repression Endocrine Reviews 2003 24 4 488 522
246. Ito K., Barnes P. J., Adcock I. M., Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1-induced histone H4 acetylation on lysines 8 and 12 Molecular and Cellular Biology 2000 20 18 6891 6903
247. Ito K., Yamamura S., Essilfie-Quaye S., Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression The Journal of Experimental Medicine 2006 203 1 7 13
248. Kagoshima M., Wilcke T., Ito K., Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation The European Journal of Pharmacology 2001 429 13 327 334
249. Saccani S., Pantano S., Natoli G., p38-dependent marking of inflammatory genes for increased NF-κB recruitment Nature Immunology 2002 3 1 69 75
250. Schulz M., Eggert M., Baniahmad A., Dostert A., Heinzel T., Renkawitz R., RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding Journal of Biological Chemistry 2002 277 29 26238 26243
251. Wang Q., Blackford J. A. Jr., Song L.-N., Huang Y., Cho S., Simons S. S. Jr., Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors Molecular Endocrinology 2004 18 6 1376 1395
252. Garside H., Stevens A., Farrow S., Glucocorticoid ligands specify different interactions with NF-κB by allosteric effects on the glucocorticoid receptor DNA binding domain Journal of Biological Chemistry 2004 279 48 50050 50059
253. Ronacher K., Hadley K., Avenant C., Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Molecular and Cellular Endocrinology 2009 299 2 219 231
254. Hart L., Sam L., Adcock I., Barnes P. J., Chung K. F., Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor B in asthma The American Journal of Respiratory and Critical Care Medicine 2000 161 1 224 231
255. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A. C. B., Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 EMBO Journal 2001 20 24 7108 7116
256. Lasa M., Brook M., Saklatvala J., Clark A. R., Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38 Molecular and Cellular Biology 2001 21 3 771 780
257. Lasa M., Abraham S. M., Boucheron C., Saklatvala J., Clark A. R., Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 Molecular and Cellular Biology 2002 22 22 7802 7811
258. Engelbrecht Y., de Wet H., Horsch K., Langeveldt C. R., Hough F. S., Hulley P. A., Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines Endocrinology 2003 144 2 412 422
259. Wu W., Chaudhuri S., Brickley D. R., Pang D., Karrison T., Conzen S. D., Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells Cancer Research 2004 64 5 1757 1764
260. Frst R., Schroeder T., Eilken H. M., MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium FASEB Journal 2007 21 1 74 80
261. Cho I. J., Kim S. G., A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR Molecular Endocrinology 2009 23 1 86 99
262. Bladh L.-G., Johansson-Haque K., Rafter I., Nilsson S., Okret S., Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-B activity by glucocorticoids Biochimica et Biophysica Acta 2009 1793 3 439 446
263. King E. M., Holden N. S., Gong W., Rider C. F., Newton R., Inhibition of NF-κB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occuring via p38 MAPK Journal of Biological Chemistry 2009 284 39 26803 26815
264. Ro H.-S., Kim S.-W., Wu D., Webber C., Nicholson T. E., Gene structure and expression of the mouse adipocyte enhancer-binding protein Gene 2001 280 1-2 123 133
265. Majdalawieh A., Zhang L., Fuki I. V., Rader D. J., Ro H.-S., Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2346 2351
266. Majdalawieh A., Zhang L., Ro H.-S., Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-κB via I B negative regulation Molecular Biology of the Cell 2007 18 3 930 942
267. Majdalawieh A., Ro H.-S., LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1 International Journal of Biochemistry and Cell Biology 2009 41 7 1518 1525
268. Reznik S. E., Fricker L. D., Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding Cellular and Molecular Life Sciences 2001 58 12-13 1790 1804
269. Xin X., Day R., Dong W., Lei Y., Fricker L. D., Identification of mouse CPX-2, a novel member of the metallocarboxypeptidase gene family: cDNA cloning, mRNA distribution, and protein expression and characterization DNA and Cell Biology 1998 17 10 897 909
270. Lei Y., Xin X., Morgan D., Pintar J. E., Fricker L. D., Identification of mouse CPX-1, a novel member of the metallocarboxypeptidase gene family with highest similarity to CPX-2 DNA and Cell Biology 1999 18 2 175 185
271. He G.-P., Muise A., Li A. W., Ro H.-S., A eukaryotic transcriptional repressor with carboxypeptidase activity Nature 1995 378 6552 92 96
272. Muise A. M., Ro H.-S., Enzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNA Biochemical Journal 1999 343 2 341 345
273. Kim S.-W., Muise A. M., Lyons P. J., Ro H.-S., Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation Journal of Biological Chemistry 2001 276 13 10199 10206
274. Lyons P. J., Muise A. M., Ro H.-S., MAPK modulates the DNA binding of adipocyte enhancer-binding protein 1 Biochemistry 2005 44 3 926 931
275. Zhang L., Reidy S. P., Nicholson T. E., The role of AEBP1 in sex-specific diet-induced obesity Molecular Medicine 2005 11 112 39 47
276. Ro H.-S., Zhang L., Majdalawieh A., Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis Obesity 2007 15 2 288 302
277. Mansour S. J., Matten W. T., Hermann A. S., Transformation of mammalian cells by constitutively active MAP kinase kinase Science 1994 265 5174 966 970
278. Wilkinson M. G., Millar J. B. A., Control of the eukaryotic cell cycle by MAP kinase signaling pathways FASEB Journal 2000 14 14 2147 2157
279. Platanias L. C., Map kinase signaling pathways and hematologic malignancies Blood 2003 101 12 4667 4679
280. Roux P. P., Blenis J., ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions Microbiology and Molecular Biology Reviews 2004 68 2 320 344
281. Rosen S. D., Kafka J. A., Simpson D. L., Barondes S. H., Developmentally regulated, carbohydrate binding protein in Dictyostelium discoideum Proceedings of the National Academy of Sciences of the United States of America 1973 70 9 2554 2557
282. Springer W. R., Cooper D. N. W., Barondes S. H., Discoidin I is implicated in cell-substratum attachment and ordered cell migration of Dictyostelium discoideum and resembles fibronectin Cell 1984 39 3 557 564
283. Johnson J. D., Edman J. C., Rutter W. J., A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain Proceedings of the National Academy of Sciences of the United States of America 1993 90 12 5677 5681
284. Prag S., Collett G. D. M., Adams J. C., Molecular analysis of muskelin identifies a conserved discoidin-like domain that contributes to protein self-association Biochemical Journal 2004 381 2 547 559
285. Delerive P., Gervois P., Fruchart J.-C., Staels B., Induction of I B expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-activators Journal of Biological Chemistry 2000 275 47 36703 36707
286. Azuma M., Motegi K., Aota K., Yamashita T., Yoshida H., Sato M., TGF-1 inhibits NF-κB activity through induction of I B-expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-1 Experimental Cell Research 1999 250 1 213 222
287. Saile B., Matthes N., El Armouche H., Neubauer K., Ramadori G., The bcl, NF-κB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGFb or TNF on activated hepatic stellate cells The European Journal of Cell Biology 2001 80 8 554 561
288. Park J.-G., Muise A., He G.-P., Kim S.-W., Ro H.-S., Transcriptional regulation by the 5 subunit of a heterotrimeric G protein during adipogenesis EMBO Journal 1999 18 14 4004 4012
289. Kane W. H., Davie E. W., Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin Proceedings of the National Academy of Sciences of the United States of America 1986 83 18 6800 6804
290. Stubbs J. D., Lekutis C., Singer K. L., cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences Proceedings of the National Academy of Sciences of the United States of America 1990 87 21 8417 8421
291. Vijayasarathy C., Takada Y., Zeng Y., Bush R. A., Sieving P. A., Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations Investigative Ophthalmology and Visual Science 2007 48 3 991 1000
292. Arakawa A., Matsuo-Takasaki M., Takai A., The secreted EGF-Discoidin factor xDel1 is essential for dorsal development of the Xenopus embryo Developmental Biology 2007 306 1 160 169
293. Baumgartner S., Hofmann K., Chiquet-Ehrismann R., Bucher P., The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction Protein Science 1998 7 7 1626 1631
294. Sen R., Baltimore D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 1986 46 5 705 716
295. Thompson J. E., Phillips R. J., Erdjument-Bromage H., Tempst P., Ghosh S., I B-regulates the persistent response in a biphasic activation of NF-κB Cell 1995 80 4 573 582
296. Inoue J.-I., Kerr L. D., Kakizuka A., Verma I. M., I B, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the I B family Cell 1992 68 6 1109 1120
297. Whiteside S. T., Epinat J.-C., Rice N. R., Israel A., I B, a novel member of the I B family, controls RelA and cRel NF-κB activity EMBO Journal 1997 16 6 1413 1426
298. Nolan G. P., Fujita T., Bhatia K., The bcl-3 proto-oncogene encodes a nuclear I B-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner Molecular and Cellular Biology 1993 13 6 3557 3566
299. Mercurio F., DiDonato J. A., Rosette C., Karin M., p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction Genes Development 1993 7 4 705 718
300. Fujita T., Nolan G. P., Ghosh S., Baltimore D., Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB Genes Development 1992 6 5 775 787
301. Lin R., Gewert D., Hiscott J., Differential transcriptional activation in vitro by NF-κB/Rel proteins Journal of Biological Chemistry 1995 270 7 3123 3131
302. Pomerantz J. L., Denny E. M., Baltimore D., CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex EMBO Journal 2002 21 19 5184 5194
303. Chinetti G., Griglio S., Antonucci M., Activation of proliferator- activated receptors and induces apoptosis of human monocyte-derived macrophages Journal of Biological Chemistry 1998 273 40 25573 25580
304. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor-is a negative regulator of macrophage activation Nature 1998 391 6662 79 82
305. Zhou Y.-C., Waxman D. J., Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-(PPAR) signaling pathways: growth hormone inhibition of PPAR transcriptional activity mediated by STAT5b Journal of Biological Chemistry 1999 274 5 2672 2681
306. Straus D. S., Pascual G., Li M., 15-deoxy-12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway Proceedings of the National Academy of Sciences of the United States of America 2000 97 9 4844 4849
307. Joseph S. B., Castrillo A., Laffitte B. A., Mangelsdorf D. J., Tontonoz P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors Nature Medicine 2003 9 2 213 219
308. Castrillo A., Joseph S. B., Marathe C., Mangelsdorf D. J., Tontonoz P., Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages Journal of Biological Chemistry 2003 278 12 10443 10449
309. Welch J. S., Ricote M., Akiyama T. E., Gonzalez F. J., Glass C. K., PPAR and PPAR negatively regulate specific subsets of lipopolysaccharide and IFN target genes in macrophages Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6712 6717
310. Chang L., Zhang Z., Li W., Dai J., Guan Y., Wang X., Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-κB pathway Biochemical and Biophysical Research Communications 2007 357 3 772 778
311. Bonfield T. L., Thomassen M. J., Farver C. F., Peroxisome proliferator-activated receptor-regulates the expression of alveolar macrophage macrophage colony-stimulating factor The Journal of Immunology 2008 181 1 235 242
312. Park S. J., Lee K. S., Kim S. R., Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation The Journal of Immunology 2009 183 5 3259 3267
313. Chung S. W., Kang B. Y., Kim S. H., Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-and nuclear factor-B Journal of Biological Chemistry 2000 275 42 32681 32687
314. Weil R., Sirma H., Giannini C., Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor I B Molecular and Cellular Biology 1999 19 9 6345 6354
315. Gao H., Sun Y., Wu Y., Identification of-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways Molecular Cell 2004 14 3 303 317
316. Lee D.-K., Kang J.-E., Park H.-J., FBI-1 enhances transcription of the nuclear factor-B (NF-κB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-κB Journal of Biological Chemistry 2005 280 30 27783 27791
317. Le Negrate G., Krieg A., Faustin B., Chla Dub1 of Chlamydia trachomatis suppresses NF-κB activation and inhibits I B ubiquitination and degradation Cellular Microbiology 2008 10 9 1879 1892
318. Sorriento D., Ciccarelli M., Santulli G., The G-protein-coupled receptor kinase 5 inhibits NF B transcriptional activity by inducing nuclear accumulation of I B Proceedings of the National Academy of Sciences of the United States of America 2008 105 46 17818 17823
319. Doceul V., Charleston B., Crooke H., Reid E., Powell P. P., Seago J., The Npro product of classical swine fever virus interacts with I B, the NF-κB inhibitor The Journal of General Virology 2008 89 8 1881 1889
320. Kopp E. B., Medzhitov R., The Toll-receptor family and control of innate immunity Current Opinion in Immunology 1999 11 1 13 18
321. Zhang G., Ghosh S., Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors The Journal of Endotoxin Research 2000 6 6 453 457